Fixed-Ratio Blend Guide
Growth hormone axis
Calculate fixed-ratio Tesamorelin + Ipamorelin vial math from the exact labeled component amounts while keeping the marketed blend separate from product-specific tesamorelin evidence and approval status.
The button above prefills editable component names only. Enter every mass from the actual vial label before using the result. BACToBasics does not use a named blend as authority for a universal formulation, preparation protocol, or amount to use.
Marketed Tesamorelin + Ipamorelin blends appear in multiple component ratios. Tesamorelin also has FDA-approved, product-specific formulations and indications; that status does not transfer to an independently marketed combination vial. Use the exact label and review each component separately.
Tesamorelin + Ipamorelin is marketed in more than one component split. BACToBasics therefore prefills only the two names and leaves both masses blank so the calculation stays tied to the actual vial rather than a ratio copied from another product.
After both labeled masses and the shared liquid volume are entered, the calculator determines each concentration. Every draw then contains the same fraction of the tesamorelin and ipamorelin originally labeled in that vial.
Tesamorelin has product-specific U.S. approval, while a separately marketed Tesamorelin + Ipamorelin blend is a different formulation. BACToBasics keeps regulatory context attached to the exact component and product instead of treating the combination name as an approved fixed-dose product.
A pre-blended vial does not create combination-specific efficacy or safety evidence. Use the individual Tesamorelin and Ipamorelin guides and Research Library entries for evidence claims, formulation details, and source links.
None. Marketed vials use different component splits, so the Blend Calculator requires the exact masses printed on the vial.
No. Tesamorelin's approval is product- and indication-specific. BACToBasics does not treat an independently marketed combination vial as the same approved product.
Component evidence
BACToBasics derives these links from the blend's component metadata, connecting the blend page to direct comparisons, filtered research records, and clinical-development context when those surfaces exist.
Compare the components side by side by evidence, regulatory status, mechanism, and safety context.
Open →
UpdatesOpen the component's public research and clinical-development timeline.
Open →
ResearchOpen the component-specific Research Library records.
Open →
DevelopmentApproved · Approved.
Open →
UpdatesOpen the component's public research and clinical-development timeline.
Open →
ResearchOpen the component-specific Research Library records.
Open →
DevelopmentPhase 2 (historical) · Historical clinical development.
Open →
More vial math
Fixed-ratio vial-label math for a CJC-1295 + Ipamorelin blend.
Open guide →
Fixed-ratio vial math for marketed Sermorelin + Ipamorelin combinations.
Open guide →
Label math for CJC-1295 + GHRP-2 blends with an explicit No DAC naming warning.
Open guide →
Published September 6, 2026. BACToBasics provides educational information and mathematical conversion tools only. This page is not medical advice, dosing advice, preparation instruction, treatment guidance, or a recommendation to use or combine any peptide or research compound.